Contacts: John D Harkrider, Michael L Keeley (co-chairs)
Emails: firstname.lastname@example.org, email@example.com
Axinn combines the skills, experience and dedication of the world's largest firms with the focus, responsiveness, efficiency and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on nearly US$500 billion in transactions and, in the past 10 years alone, have handled more than 250 litigations.
Experience speeds results in high-stakes competition disputes, and real numbers are the measure of our success. Axinn’s 60-plus full-time antitrust lawyers have successfully guided nearly half a trillion dollars in mergers through second requests and extended reviews. We have been global lead or co-lead on some of the most significant recent transactions, including: Dell’s $67 billion acquisition of EMC; Thermo Fisher’s $13.2 billion acquisition of Life Technologies and $12.5 billion tender offer of Qiagen; Sunrun’s $3.2 billion acquisition of Vivint Solar; Tyson Foods’ $2.16 billion acquisition of Keystone Foods; Ball Corporation’s $6 billion acquisition of Rexam; Johnson Controls’ $2 billion sale of Scott Safety to 3M; McKesson’s $3.4 billion joint venture with Change Healthcare; and Google’s most complex deals, including Motorola Mobility and ITA Software.
Axinn attorneys also have 360-plus years of combined experience in Sherman Act litigation and class actions, cartel matters and government investigations. In the last year alone, we have defended over $450 billion in potential antitrust damages. Our extensive antitrust litigation experience includes the In Re Blue Cross antitrust litigation (for IBC); multiple major treble-damage class action litigations and regulatory investigations (for Tyson Foods); a patent infringement and antitrust litigation regarding Indivior’s opioid dependency treatment drug Suboxone® Film and the Generic Drugs MDL (for Alvogen); the In Re Surescripts monopolisation class action (for RelayHealth (McKesson)); the class action lawsuit alleging price fixing in caustic soda (for Shin-Tech); SawStop (for Stanley Black & Decker); parallel antitrust litigations (for Momenta); the German and Asian Auto Parts litigation; as well as monopolisation and conspiracy cases for Thermo Fisher, Danfoss, Hexcel, the University of Pittsburgh Medical Center and Affinia.
The firm has litigated six merger cases brought by government agencies (winning five) and has a strong presence and track record in ongoing DOJ criminal antitrust matters and related litigation, including in auto parts and air cargo. The antitrust group has extensive experience on matters involving antitrust and IP issues, including Google’s settlement with the Federal Trade Commission on standard essential patents and was lead counsel in a major litigation involving biosimilars. Axinn has deep contacts with the staff and front offices of the FTC and the DOJ in both Republican and Democratic administrations, and employs lawyers with more than 60 years of combined government antitrust experience.
Axinn works across the following industries:
Recognition/awards from Global Competition Review
New York, USA
114 West 47th Street
Washington DC, USA
950 F Street, NW
San Francisco, USA
560 Mission Street
90 State House Square